[go: up one dir, main page]

ZA200700138B - Improvement of barrier integrity in HIV patients - Google Patents

Improvement of barrier integrity in HIV patients Download PDF

Info

Publication number
ZA200700138B
ZA200700138B ZA200700138A ZA200700138A ZA200700138B ZA 200700138 B ZA200700138 B ZA 200700138B ZA 200700138 A ZA200700138 A ZA 200700138A ZA 200700138 A ZA200700138 A ZA 200700138A ZA 200700138 B ZA200700138 B ZA 200700138B
Authority
ZA
South Africa
Prior art keywords
acid
composition
oligosaccharides
ara
composition according
Prior art date
Application number
ZA200700138A
Other languages
English (en)
Inventor
Van Tol Eric Alexander Franciscus
Willemsen Linette Eustachia Maria
Koetsier Marleen Antoinette
Beermann Christopher
Stahl Bernd
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34957849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200700138(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of ZA200700138B publication Critical patent/ZA200700138B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/03—Organic compounds
    • A23L29/035—Organic compounds containing oxygen as heteroatom
    • A23L29/04—Fatty acids or derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/30—Foods or foodstuffs containing additives; Preparation or treatment thereof containing carbohydrate syrups; containing sugars; containing sugar alcohols, e.g. xylitol; containing starch hydrolysates, e.g. dextrin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Glass Compositions (AREA)
ZA200700138A 2004-06-22 2005-06-22 Improvement of barrier integrity in HIV patients ZA200700138B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2004/000444 WO2005122790A1 (en) 2004-06-22 2004-06-22 Improvement of intestinal barrier integrity

Publications (1)

Publication Number Publication Date
ZA200700138B true ZA200700138B (en) 2008-05-28

Family

ID=34957849

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200700138A ZA200700138B (en) 2004-06-22 2005-06-22 Improvement of barrier integrity in HIV patients

Country Status (20)

Country Link
US (4) US8252769B2 (ru)
EP (3) EP1672987B1 (ru)
JP (1) JP4903695B2 (ru)
CN (1) CN100589712C (ru)
AT (2) ATE429155T1 (ru)
AU (1) AU2004320743B2 (ru)
BR (1) BRPI0418921A (ru)
CA (1) CA2570205C (ru)
CY (1) CY1109224T1 (ru)
DE (2) DE602004020813D1 (ru)
DK (3) DK1815755T3 (ru)
ES (3) ES2431363T3 (ru)
NZ (1) NZ552166A (ru)
PL (3) PL1815755T3 (ru)
PT (3) PT1815755E (ru)
RU (1) RU2402240C2 (ru)
SI (1) SI1815755T1 (ru)
UA (1) UA81875C2 (ru)
WO (1) WO2005122790A1 (ru)
ZA (1) ZA200700138B (ru)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
NZ552118A (en) * 2004-06-22 2010-03-26 Nutricia Nv Improvement of barrier integrity in HIV patients with fatty acids
EP1723951A1 (en) † 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1721611A1 (en) * 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
CA2537452C (en) * 2005-03-09 2013-12-24 Abbott Laboratories Concentrated human milk fortifier liquid
EP1714660A1 (en) * 2005-04-21 2006-10-25 N.V. Nutricia Uronic acid and probiotics
EP1871181B2 (en) * 2005-04-21 2016-12-21 N.V. Nutricia Nutritional supplement for hiv patients
EP1776877A1 (en) * 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
ES2366034T3 (es) 2005-12-23 2011-10-14 N.V. Nutricia Composición que comprende ácidos grasos poliinsaturados, proteínas, manganeso y/o molibdeno y nucleósidos/nucleótidos para el tratamiento de la demencia.
JP4771882B2 (ja) * 2006-07-21 2011-09-14 味の素ゼネラルフーヅ株式会社 糖尿病または糖尿病性合併症の治療、予防、または改善作用を有する組成物およびこれを含有する飲料
CN101795579A (zh) * 2006-08-04 2010-08-04 Shs国际有限公司 无蛋白配方
EP1969952A1 (en) * 2007-03-07 2008-09-17 Friesland Brands B.V. Allergen-free or dairy free LCPUFA powdered compositions and the use thereof in food products and especially infant formulas
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
US20100261642A1 (en) * 2007-09-17 2010-10-14 N.V. Nutricia Nutritional formulation with high energy content
WO2009096772A1 (en) * 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
EP2130440A1 (en) * 2008-06-06 2009-12-09 N.V. Nutricia Inhibiting E. sakazakii growth
AR072141A1 (es) 2008-06-13 2010-08-11 Nutricia Nv Composicion nutricional para lactantes nacidos por cesarea
RU2497388C2 (ru) 2008-09-02 2013-11-10 Н.В. Нютрисиа Питательные композиции с липидными глобулами с сердцевиной, содержащей растительные жиры, и покрытием, содержащим фосфолипиды или полярные липиды
WO2010068086A1 (en) 2008-12-11 2010-06-17 N.V. Nutricia Nutritional compositions with large lipid globule size
JP5738180B2 (ja) * 2009-03-26 2015-06-17 味の素ゼネラルフーヅ株式会社 生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品
WO2010109626A1 (ja) 2009-03-26 2010-09-30 味の素ゼネラルフーヅ株式会社 生活習慣病を予防または治療するための医薬組成物およびそれに役立つ食品
MX336032B (es) * 2009-11-12 2016-01-07 Nestec Sa Composicion nutricional para promover el balance y salud de la microbiota intestinal.
WO2011115476A1 (en) * 2010-03-17 2011-09-22 N.V. Nutricia Infant nutrition for improving fatty acid composition of brain membranes later in life
CA2796936A1 (en) * 2010-04-26 2011-11-10 Nestec S.A. Nutritional compositions and methods for weaning from parenteral nutrition to enteral nutrition
CN103153095B (zh) * 2010-08-24 2015-07-22 雅培制药有限公司 具有改良感官特性的营养产品
EP2488042B1 (en) 2010-11-02 2013-10-02 Abbott Laboratories Stable concentrated liquid human milk fortifier
SG10202110501RA (en) 2010-12-31 2021-11-29 Abbott Lab Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
MX338174B (es) 2010-12-31 2016-04-06 Abbott Lab Metodos para reducir la incidencia de la tension oxidativa al usar los oligosacaridos de leche humana, la vitamina c y los agentes antiinflamatorios.
WO2012177118A1 (en) 2011-06-22 2012-12-27 N.V. Nutricia Method for reducing the occurrence of infection in young children
PH12014500185A1 (en) 2011-07-22 2019-10-11 Abbott Lab Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
MY169326A (en) 2011-08-29 2019-03-21 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2013057062A1 (en) 2011-10-18 2013-04-25 Nestec S.A. Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
WO2014092564A1 (en) 2012-12-10 2014-06-19 N.V. Nutricia Nutritional composition with non digestible oligosaccharides
US9352020B2 (en) * 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
CN105873458B (zh) 2013-11-01 2024-11-15 N·V·努特里奇亚 用于在追赶性生长期间改善体躯成分的脂质组合物
BR112016009357B1 (pt) 2013-11-04 2021-09-14 N.V. Nutricia Usos de um ingrediente fermentado e oligossacarídeos não digeríveis na fabricação de uma fórmula para fórmula para recém-nascido ou de continuação para uso na redução da incidência de cólicas em um recém-nascido
US9815473B2 (en) 2014-01-30 2017-11-14 Ford Global Technologies, Llc Manual transmission clutch control using driveline measurements
CN107209173B (zh) * 2015-01-23 2020-02-07 雀巢产品有限公司 用于确定患者的独特的营养需求的方法
WO2017064304A1 (en) 2015-10-15 2017-04-20 N.V. Nutricia Infant formula with special lipid architecture for promoting healthy growth
CN105231461A (zh) * 2015-10-30 2016-01-13 中营康园（北京）科技有限公司 一种提高机体免疫力的营养组合物及其应用
CN110177467A (zh) 2016-12-09 2019-08-27 N·V·努特里奇亚 用于改善细胞膜的营养组合物
CA3060243A1 (en) 2017-04-17 2018-10-25 The University Of Chicago Polymer materials for delivery of short-chain fatty acids to the intestine for applications in human health and treatment of disease
HUE055897T2 (hu) 2017-05-12 2021-12-28 Evonik Operations Gmbh Eljárás C. perfringens által okozott betegségek detektálására állatokban
CN107198250B (zh) * 2017-05-23 2019-03-12 北京瑞千景科技发展有限公司 改善肠道微生态预防慢性病组合物和均衡营养食品及应用
CN111801579A (zh) 2018-03-02 2020-10-20 赢创运营有限公司 用于检测动物中的肠屏障衰竭的体外方法
CN109527123A (zh) * 2018-12-14 2019-03-29 大连大学 一种对慢性肠炎具有改善作用的调和油
PH12021552677A1 (en) 2019-05-15 2022-07-04 Nutricia Nv Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
LT3883393T (lt) 2019-06-04 2022-12-27 N.V. Nutricia Mitybinė kompozicija, apimanti 2‘-fukozil-laktozę ir maistinį butiratą
HUE063680T2 (hu) 2019-06-04 2024-01-28 Nutricia Nv 2'-fukozillaktózt és 3'-galaktozillaktózt tartalmazó táplálkozási készítmény
PL437793A1 (pl) * 2021-05-07 2022-11-14 Uniwersytet Medyczny w Łodzi Zastosowanie masła Ghee otrzymywanego z siary bydlęcej (colostrum)
GB2608587B (en) * 2021-06-25 2025-01-01 Mjn Us Holdings Llc Use of extensively hydrolysed protein
WO2023275391A1 (en) * 2021-07-01 2023-01-05 N.V. Nutricia Nutritonal compositions for gut barrier function

Family Cites Families (132)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2981629A (en) * 1960-04-05 1961-04-25 Lewis F Ginnette Process of dehydrating foams
DE2033677A1 (de) 1970-07-07 1972-02-17 Deutsche Laevosan Gesellschaft C F Boehringer & Sohne GmbH & Co KG, Suddeutsche Zucker AG, 6800 Mannheim Arzneimittel
US4237118A (en) * 1972-03-06 1980-12-02 Howard Alan N Dietary supplement and dietary methods employing said supplement for the treatment of obesity
JPS5645951B2 (ru) * 1973-05-21 1981-10-29
JPS5263224A (en) 1975-11-20 1977-05-25 Asahi Chem Ind Co Ltd Resin compositions for coating powder with low-temperature curing prop erty
JPS5342340A (en) 1976-09-29 1978-04-17 Shin Kobe Electric Machinery Method of producing battery plate
DE2844861A1 (de) 1978-10-14 1980-04-30 Kerstein Pharma Hameln Gmbh Diaetetisches lebensmittel zur oralen oder kuenstlichen ernaehrung und verfahren zu seiner herstellung
FR2490496A1 (fr) * 1980-09-19 1982-03-26 Roussel Uclaf Nouvelles glycoproteines immunostimulantes extraites de klebsiella pneumoniae, leur procede d'obtention, leur application a titre de medicaments et les compositions les renfermant
US4438147A (en) * 1982-06-25 1984-03-20 Societe D'assistance Technique Pour Produits Nestle S.A. Foaming creamer and method of making same
CA1324529C (en) 1987-09-15 1993-11-23 Tatsuhiko Kan Liquid food comprising polydextrose and oligosaccharides
DE3734962C1 (de) 1987-10-15 1989-01-05 Luitpold Werk Chem Pharm Verwendung von Chondroitinpolysulfat zur vorbeugenden,lindernden oder heilenden Behandlung von AIDS und ARC
ATE84217T1 (de) 1988-08-24 1993-01-15 Akzo Nv Fragmente und fraktionen von heparin mit wirkung gegen hiv.
JP2782443B2 (ja) * 1988-12-26 1998-07-30 將純 吉原 抗エイズウィルス剤
DE3901048A1 (de) 1989-01-14 1990-07-19 Chimicasa Gmbh Antikachectikum
JP2779963B2 (ja) 1989-02-09 1998-07-23 株式会社林原生物化学研究所 ビフィズス菌増殖促進剤
JPH02286058A (ja) 1989-04-28 1990-11-26 Nippon Synthetic Chem Ind Co Ltd:The 整腸剤
ES2033193B1 (es) 1990-10-30 1994-01-16 Ganadera Union Ind Agro Mezcla grasa para nutricion infantil y de adultos.
CA2101274C (en) * 1991-01-24 1998-12-15 David J. Kyle Microbial oil mixtures and uses thereof
FR2673812B1 (fr) 1991-03-13 1994-04-01 Roussel Uclaf Nouvelles compositions destinees a etre utilisees en dietetique et en therapeutique et renfermant une combinaison particuliere de glucides et leurs applications.
GB9109125D0 (en) 1991-04-27 1991-06-12 Cerestar Holding Bv Sweetening composition
IT1248060B (it) 1991-06-14 1995-01-05 Italfarmaco Spa Eparine acilate come inibitori della replicazione di retrovirus
GB9116054D0 (en) 1991-07-24 1991-09-11 Efamol Holdings Preparation of fatty acid medicaments
US5629023A (en) * 1991-12-31 1997-05-13 Bland; Jeffrey S. Medical food composition for metabolic detoxification
DE69312851T2 (de) 1992-04-10 1998-01-08 Otsuka Pharmaceutical Co., Ltd., Tokio/Tokyo Nahrungsmittelzusammensetzung zur hemmung von der bildung von darmverrottungsprodukten
CA2089607C (en) 1992-11-05 1997-11-04 Ranjit K. Chandra Nutritional supplement for the elderly
US5372852A (en) * 1992-11-25 1994-12-13 Tektronix, Inc. Indirect printing process for applying selective phase change ink compositions to substrates
US5502041A (en) * 1992-12-11 1996-03-26 The Center For Innovative Technology Potent inhibitor of HIV reverse transcriptase
GB9304746D0 (en) 1993-03-09 1993-04-28 Scotia Holdings Plc Treatment of viral infections
US5472952A (en) * 1993-03-18 1995-12-05 Bristol-Myers Squibb Company Partially hydrolyzed pectin in nutritional compositions
US5405637A (en) 1993-06-30 1995-04-11 Bristol-Myers Squibb Company Milk protein partial hydrolysate and infant formula containing same
GB9318611D0 (en) 1993-09-08 1993-10-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
JP3310738B2 (ja) * 1993-11-10 2002-08-05 株式会社ロッテ 低カロリーチョコレート
DE4404877C1 (de) 1994-02-17 1995-03-02 Ksk Industrielackierungen Gmbh Lackierverfahren und zur Durchführung des Verfahrens geeignete Lackgießvorrichtung
US5444054A (en) * 1994-04-01 1995-08-22 Abbott Labatories Method of treating ulcerative colitis
US5952314A (en) * 1994-04-01 1999-09-14 Demichele; Stephen Joseph Nutritional product for a person having ulcerative colitis
CA2187628C (en) 1994-04-01 2002-05-14 Stephen Joseph Demichele Nutritional product for treatment of ulcerative colitis and use thereof
EP0692252B1 (en) 1994-06-14 2001-04-04 "Raffinerie Tirlemontoise", société anonyme: Use of a composition containing inulin or oligofructose in cancer treatment
JP3419897B2 (ja) * 1994-07-22 2003-06-23 明治乳業株式会社 低アレルギー性調製乳
NL9401644A (nl) 1994-10-06 1996-05-01 Friesland Brands Bv Voedingsmiddel voor zwangere en lacterende vrouwen
US5531988A (en) * 1994-10-28 1996-07-02 Metagenics, Inc. Bacteria and immunoglobulin-containing composition for human gastrointestinal health
US5531989A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
EP0711503A3 (en) 1994-11-14 1997-11-26 Scotia Holdings Plc Milk fortified with GLA and/or DGLA
JPH08151328A (ja) 1994-11-28 1996-06-11 Fuji Ratetsukusu Kk エイズ感染防止潤滑剤
US5733579A (en) * 1995-04-05 1998-03-31 Abbott Laboratories Oral rehydration solution containing indigestible oligosaccharides
US6099871A (en) 1995-06-01 2000-08-08 Bristol-Myers Squibb Company Anti-regurgitation infant formula
US20020016289A1 (en) * 1995-06-01 2002-02-07 Orla M. Conneely Methods for treatment and prevention of helicobacter pylori infection using lactoferrin
US5827526A (en) 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
EP0756828B2 (en) * 1995-08-04 2010-09-22 N.V. Nutricia Nutritional composition containing fibres
JPH0965855A (ja) 1995-08-28 1997-03-11 Otsuka Shokuhin Kk 低カロリー整腸食品素材
MY115050A (en) * 1995-10-16 2003-03-31 Mead Johnson Nutrition Co Diabetic nutritional product having controlled absorption of carbohydrate
AUPN881396A0 (en) 1996-03-20 1996-04-18 Arnott's Biscuits Limited Enhancement of microbial colonization of the gastrointestinal tract
CA2205773A1 (en) 1996-06-21 1997-12-21 Kraft Foods, Inc. Creamy, thick, hot beverage foam
ATE227521T1 (de) 1996-07-31 2002-11-15 Sraffinerie Tirlemontoises Sa Fruktan- und/oder polydextrose enthaltende milchproduktpulver; verfahren zu ihrer herstellung und verwendung derselben
FR2752381B1 (fr) * 1996-08-13 1998-11-06 Pierre Moreau Biotechnologie aviaire, micro nutriments biodisponibles. prevention et traitement de la physiopathologie specifique des maladies de degenerescence et du vieillissement
JP3792309B2 (ja) 1996-08-30 2006-07-05 サントリー株式会社 不飽和脂肪酸含有油脂の製造方法
GB9619660D0 (en) 1996-09-20 1996-11-06 Scient Hospital Suppl Int Ltd Prevention of gastrointestinal damage
JPH10108647A (ja) * 1996-10-08 1998-04-28 Meiji Seika Kaisha Ltd 胃切除術後患者用ミネラル補給材
ATE233557T1 (de) 1996-11-05 2003-03-15 Wisconsin Alumni Res Found Verwendung von konjugiertes linolensäure zur steigerung der aktivität von natural killer- lymphozyten
JP4008974B2 (ja) 1996-12-12 2007-11-14 森永乳業株式会社 ビフィズス菌増殖促進組成物及びその用途
AUPO430496A0 (en) 1996-12-19 1997-01-23 Arnott's Biscuits Limited Prebiotics and probiotics
DE19701382A1 (de) * 1997-01-16 1998-07-23 Nutricia Nv Kohlenhydratmischung
RU2199317C2 (ru) * 1997-02-21 2003-02-27 Абботт Лаборэтриз Способ снижения заболеваемости некротическим энтероколитом у детей (варианты)
US5840361A (en) * 1997-04-09 1998-11-24 Beech-Nut Nutrition Corporation Fructan-containing baby food compositions and methods therefor
CN1253588A (zh) 1997-04-11 2000-05-17 艾博特公司 在植物中合成长链多不饱和脂肪酸的方法和组合物
NL1005809C2 (nl) * 1997-04-14 1998-10-19 Dsm Nv Poederverfbindmiddelsamenstelling.
US5846569A (en) * 1997-06-20 1998-12-08 Creative Labs, Inc. Colostrum supplement
US6051260A (en) * 1998-04-07 2000-04-18 Healthcomm International, Inc. Medical food composition of reduced allergenicity, especially adapted for improving gut mucosal integrity
GB9808579D0 (en) 1998-04-22 1998-06-24 Novartis Nutrition Ag Improvements in or relating to organic compounds
EP0958825A1 (en) 1998-05-18 1999-11-24 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Synergistic composition of a non-digestible carbohydrate and an anti-cancer drug for use in the treatment of cancer
FR2781673B1 (fr) 1998-07-28 2001-09-28 Univ Picardie Utilisation d'un glucuronane en tant qu'agent immunostimulant, procede de preparation
DE19836339B4 (de) * 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US6231889B1 (en) * 1998-09-21 2001-05-15 Chronorx, Llc Unit dosage forms for the treatment of herpes simplex
US6794495B1 (en) * 1998-10-19 2004-09-21 New Nordic Danmark Aps Composition comprising extensin and, optionally, pectic polysaccharides
ATE278329T1 (de) * 1999-01-28 2004-10-15 Nestle Sa Aromatisiertes lösliches aufhellerpulver
EP1074181A1 (en) 1999-08-03 2001-02-07 Societe Des Produits Nestle S.A. Foaming creamer ingredient and powders containing it
DE19940011B4 (de) 1999-08-24 2009-04-02 Schütte/Reichel GbR (vertretungsberechtigte Gesellschafter: Irene Schütte Alginataufbereitung und deren Verwendung
US6737089B2 (en) * 1999-08-27 2004-05-18 Morinda, Inc. Morinda citrifolia (Noni) enhanced animal food product
EP1062873A1 (en) 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
DE10006989A1 (de) 2000-02-16 2001-08-23 Nutricia Nv Antiadhäsive Kohlenhydratmischung
US6846501B2 (en) * 2000-04-12 2005-01-25 Mid-America Commercialization Corporation Traditional snacks having balanced nutritional profiles
US6495599B2 (en) * 2000-04-13 2002-12-17 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses therof
EP1155627A1 (en) 2000-05-18 2001-11-21 Belovo Eggs & Egg Products Eggs with balanced lipid composition
DE10027050A1 (de) 2000-06-02 2001-12-13 Karim Balan Alginathaltige Zusammensetzung und deren Verwendung
US6426110B1 (en) * 2000-08-11 2002-07-30 Global Health Sciences, Inc. Low-carbohydrate high-protein creamer powder
US20020044988A1 (en) * 2000-08-22 2002-04-18 Fuchs Eileen C. Nutritional composition and method for improving protein deposition
US7491518B2 (en) 2000-08-30 2009-02-17 Amano Enzyme Inc. Method of elevating yield of oligosaccharides containing α-galactosyl and anti-candida compositions
CN1111541C (zh) 2000-09-15 2003-06-18 青岛海洋大学 一种聚甘露糖醛酸硫酸盐
US20050238655A1 (en) 2004-01-06 2005-10-27 Paul Stamets Antiviral activity from medicinal mushrooms
AU2002243267A1 (en) 2000-10-27 2002-06-24 Mannatech, Inc. Dietary supplement compositions
EP1208792A1 (de) * 2000-11-17 2002-05-29 Haag-Streit Ag Vorrichtung und Verfahren zur Untersuchung und/oder Behandlung eines Auges
DE10057976B4 (de) 2000-11-22 2005-02-03 Südzucker AG Mannheim/Ochsenfurt Verfahren zur Herstellung von Pektinhydrolyseprodukten
US6511696B2 (en) * 2000-12-13 2003-01-28 Novartis Nutrition Ag Infant formula with free amino acids and nucleotides
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
WO2002060283A2 (en) 2001-01-30 2002-08-08 Unilever N.V. Food product comprising protein coated gas microbubbles
EP1228694A1 (en) 2001-02-02 2002-08-07 Societe Des Produits Nestle S.A. Aromatizing agent
CN1457357A (zh) * 2001-02-15 2003-11-19 旭电化工业株式会社 包含β－葡聚糖的制品
EP1243273A1 (en) 2001-03-22 2002-09-25 Societe Des Produits Nestle S.A. Composition comprising a prebiotic for decreasing infammatory process and abnormal activation of non-specific immune parameters
JP3814494B2 (ja) * 2001-04-27 2006-08-30 松下電器産業株式会社 色管理装置及び色管理システム
DE10136260B4 (de) 2001-07-25 2004-07-08 Südzucker AG Mannheim/Ochsenfurt Inulin in Geliermittelzusammensetzungen
NL1018832C2 (nl) 2001-08-27 2003-03-03 Friesland Brands Bv Melkvervangend voedingsmiddel omvattend johannesbroodpitmeel.
JP2003146887A (ja) 2001-11-07 2003-05-21 Gotoo Corporation:Kk Ｎｋ細胞活性化作用を有する製剤および飲食品
AU2003245252A1 (en) 2002-04-30 2003-11-17 Fmc Corporation Carrageenan based antimicrobial compositions
US6623954B1 (en) 2002-05-28 2003-09-23 Neose Technologies, Inc. Process for removal of phosphorous from a dairy stream
CN100469361C (zh) 2002-06-19 2009-03-18 纽迪希亚公司 治疗或预防哺乳动物遭受代谢作用压力时的分解代谢或刺激性合成代谢的方法及组合物
EP1374878A1 (en) 2002-06-20 2004-01-02 N.V. Nutricia Method and composition for preventing or alleviating symptoms of malabsorption from the gastrointestinal tract
US20060110516A1 (en) * 2002-08-30 2006-05-25 Holtus Maria F Foaming ingredient and products containing the ingredient
US20040122105A1 (en) * 2002-09-20 2004-06-24 Griscom Bettle Transdermal compositions
US20040087490A1 (en) 2002-09-20 2004-05-06 Troup John P. Nutritional compositions
US6974841B1 (en) * 2002-09-27 2005-12-13 Rapisarda Family Irrevocable Trust Pet anti-aging wellness supplement
GB0229015D0 (en) 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
US20040219188A1 (en) * 2003-05-02 2004-11-04 Comer Gail M. Composition and methods for nutritional management of patients with hepatic disease
ES2416287T3 (es) 2003-06-23 2013-07-31 Nestec S.A. Empleo de una fórmula nutritiva para la función óptima de la barrera intestinal
US20070110849A1 (en) 2003-06-23 2007-05-17 Marie-Christine Secretin Infant or follow-on formula
EP1491570A1 (en) 2003-06-25 2004-12-29 DSM IP Assets B.V. Powder coating composition for low temperature cure
AU2003904192A0 (en) * 2003-08-11 2003-08-21 Adelaide Research and Innovaiton Pty Ltd Method for inhibiting bacterial colonisation
EP1733730B1 (en) 2003-10-24 2008-07-09 N.V. Nutricia Immunemodulating oligosaccharides
CA2543626C (en) 2003-10-24 2013-08-27 N.V. Nutricia Synbiotic composition for infants
FR2866203B1 (fr) 2004-02-13 2006-12-08 Roquette Freres Procede de fabrication d'un produit de cuisson a base de gluten
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1723951A1 (en) 2005-04-21 2006-11-22 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
EP1721611A1 (en) * 2005-04-21 2006-11-15 N.V. Nutricia Nutritional supplement with oligosaccharides for a category of HIV patients
NZ552118A (en) * 2004-06-22 2010-03-26 Nutricia Nv Improvement of barrier integrity in HIV patients with fatty acids
EP1778857A4 (en) 2004-07-07 2007-09-26 Gen Hospital Corp Direct activation of atiii in whole blood and plasma
WO2006007676A1 (en) 2004-07-21 2006-01-26 Amazônia Fitomedicamentos Ltda. Combination of active fractions from the plants euphorbia tirucalli l and ficos carica l. and method of treating cancer and aids
JP4653465B2 (ja) 2004-10-25 2011-03-16 泰信 小林 ナチュラルキラー細胞の増殖促進方法およびそれに用いる培養組成物
EP1871181B2 (en) * 2005-04-21 2016-12-21 N.V. Nutricia Nutritional supplement for hiv patients
US20070036839A1 (en) * 2005-07-27 2007-02-15 Jose Antonio Matji Tuduri Phosphorylated glucomannane polysaccharides containing 1-6 and 1-2 linkages increase weight gain in poultry
CA2615771A1 (en) 2005-07-29 2007-02-08 Alcon Refractivehorizons, Inc. Ophthalmic device lateral positioning system and associated methods
US20070231449A1 (en) 2006-03-30 2007-10-04 Nutracea Non-starchy rice bran polysaccharides
WO2009096772A1 (en) * 2008-02-01 2009-08-06 N.V. Nutricia Composition for stimulating natural killer cell activity
US9281963B2 (en) * 2008-12-23 2016-03-08 Persistent Systems Limited Method and system for email search

Also Published As

Publication number Publication date
DK1815755T3 (da) 2009-06-02
US11076623B2 (en) 2021-08-03
EP2100520B1 (en) 2013-07-31
NZ552166A (en) 2010-05-28
BRPI0418921A (pt) 2007-11-27
CA2570205A1 (en) 2005-12-29
PT1815755E (pt) 2009-09-03
PT2100520E (pt) 2013-11-06
US20160073669A1 (en) 2016-03-17
EP1672987B1 (en) 2007-05-30
US20130053340A1 (en) 2013-02-28
DK2100520T3 (da) 2013-10-28
DE602004006765T2 (de) 2008-01-24
JP4903695B2 (ja) 2012-03-28
DE602004006765D1 (de) 2007-07-12
ES2431363T3 (es) 2013-11-26
JP2008503568A (ja) 2008-02-07
US8252769B2 (en) 2012-08-28
CN1997290A (zh) 2007-07-11
WO2005122790A1 (en) 2005-12-29
RU2402240C2 (ru) 2010-10-27
EP2100520A3 (en) 2009-11-25
US9084433B2 (en) 2015-07-21
SI1815755T1 (sl) 2009-08-31
EP1672987A1 (en) 2006-06-28
US10499676B2 (en) 2019-12-10
DK1672987T3 (da) 2007-10-01
US20170042197A9 (en) 2017-02-16
PL1815755T3 (pl) 2009-09-30
DE602004020813D1 (de) 2009-06-04
UA81875C2 (ru) 2008-02-11
ES2285484T3 (es) 2007-11-16
EP2100520A2 (en) 2009-09-16
ATE363213T1 (de) 2007-06-15
EP1815755A1 (en) 2007-08-08
ES2323988T3 (es) 2009-07-28
CN100589712C (zh) 2010-02-17
US20080064656A1 (en) 2008-03-13
US20200281241A1 (en) 2020-09-10
PL1672987T3 (pl) 2007-10-31
EP1815755B1 (en) 2009-04-22
CA2570205C (en) 2012-10-30
ATE429155T1 (de) 2009-05-15
PT1672987E (pt) 2007-09-11
CY1109224T1 (el) 2014-07-02
AU2004320743A1 (en) 2005-12-29
AU2004320743B2 (en) 2010-04-08
RU2007102085A (ru) 2008-07-27
PL2100520T3 (pl) 2014-01-31

Similar Documents

Publication Publication Date Title
US11076623B2 (en) Intestinal barrier integrity
US20100167982A1 (en) Barrier integrity in hiv patients
JP5502817B2 (ja) 障壁の完全性の改善